These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20073067)

  • 21. Clusterin is epigenetically regulated in prostate cancer.
    Rauhala HE; Porkka KP; Saramäki OR; Tammela TL; Visakorpi T
    Int J Cancer; 2008 Oct; 123(7):1601-9. PubMed ID: 18649357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
    Watanabe K; Emoto N; Hamano E; Sunohara M; Kawakami M; Kage H; Kitano K; Nakajima J; Goto A; Fukayama M; Nagase T; Yatomi Y; Ohishi N; Takai D
    Int J Cancer; 2012 Jun; 130(11):2580-90. PubMed ID: 21702040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional epigenomics identifies genes frequently silenced in prostate cancer.
    Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
    Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions.
    Hlavna M; Raudenska M; Hudcova K; Gumulec J; Sztalmachova M; Tanhäuserova V; Babula P; Adam V; Eckschlager T; Kizek R; Masarik M
    Int J Oncol; 2012 Dec; 41(6):2237-44. PubMed ID: 23064315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global reactivation of epigenetically silenced genes in prostate cancer.
    Ibragimova I; Ibáñez de Cáceres I; Hoffman AM; Potapova A; Dulaimi E; Al-Saleem T; Hudes GR; Ochs MF; Cairns P
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1084-92. PubMed ID: 20699414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
    Lodygin D; Diebold J; Hermeking H
    Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
    Tsuruta T; Kozaki K; Uesugi A; Furuta M; Hirasawa A; Imoto I; Susumu N; Aoki D; Inazawa J
    Cancer Res; 2011 Oct; 71(20):6450-62. PubMed ID: 21868754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.
    Hart M; Nolte E; Wach S; Szczyrba J; Taubert H; Rau TT; Hartmann A; Grässer FA; Wullich B
    Mol Cancer Res; 2014 Feb; 12(2):250-63. PubMed ID: 24337069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
    Zhong Q; Wang T; Lu P; Zhang R; Zou J; Yuan S
    J Neurosci Res; 2014 May; 92(5):619-26. PubMed ID: 24496888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic regulation of microRNA expression in colorectal cancer.
    Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
    Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.
    Porkka KP; Ogg EL; Saramäki OR; Vessella RL; Pukkila H; Lähdesmäki H; van Weerden WM; Wolf M; Kallioniemi OP; Jenster G; Visakorpi T
    Genes Chromosomes Cancer; 2011 Jul; 50(7):499-509. PubMed ID: 21472816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
    Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
    Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma.
    Chen J; Feilotter HE; Paré GC; Zhang X; Pemberton JG; Garady C; Lai D; Yang X; Tron VA
    Am J Pathol; 2010 May; 176(5):2520-9. PubMed ID: 20304954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth.
    Adi Harel S; Bossel Ben-Moshe N; Aylon Y; Bublik DR; Moskovits N; Toperoff G; Azaiza D; Biagoni F; Fuchs G; Wilder S; Hellman A; Blandino G; Domany E; Oren M
    Cell Death Differ; 2015 Aug; 22(8):1328-40. PubMed ID: 25591738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.